Our patent that relates to the use of our Q Inside Safety Technology in a breast implant is jointly owned with EL. Pursuant to our agreement with EL, WE HAVE AGREED TO PAY THEM a 10% ROYALTY in any year in which sales of the Q Inside Safety Technology for breast implants to third parties exceeds 100,000 microtransponders.